|
To our knowledge, this is the first randomized study to compare PAV and CPAP in CPE priligy Compared with the values in the normal hepatic function group, the patients with mild, moderate, and severe hepatic impairment had 43, 94, and 189 higher mean values for sirolimus AUC, respectively, with no statistically significant differences in mean Cmax |
|